Safety Lancet Market Report 2026

Safety Lancet Market Overview

• Safety Lancet market size has reached to $2.14 billion in 2025 • Expected to grow to $3.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Rising Diabetes Prevalence Drives Growth In The Safety Lancet Market • Market Trend: Improving Infant Blood Sampling Safety With Unistik Heelstik • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Safety Lancet Market?

A safety lancet is a medical device used for blood sampling, typically designed for single-use. It features a sterile, spring-loaded needle or blade that automatically retracts after use to prevent accidental needlestick injuries and cross-contamination. Safety lancets are commonly used in healthcare settings for procedures such as blood glucose testing, where small, controlled amounts of blood are needed The main product types of safety lancets include push-button safety lancets, pressure-activated safety lancets, and side-button safety lancets. A push-button safety lancet is a type of medical device designed for collecting small blood samples featuring a simple push-button mechanism that, when pressed, activates a needle to puncture the skin quickly and safely for glucose testing and other blood-related diagnostics. The applications include blood glucose testing, hemoglobin testing, cholesterol testing, and cholesterol testing for end users such as hospitals and clinics, diagnostic centers and pathology laboratories, home diagnostics, etc.

What Is The Safety Lancet Market Growth Forecast?

The safety lancet market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in home diagnostics, rising chronic disease burden, stricter occupational safety regulations, increasing preventive healthcare screening, expansion of point-of-care diagnostics. Major trends in the forecast period include rising adoption of safety-engineered blood collection devices, growing preference for single-use disposable lancets, increasing home-based diagnostic testing, enhanced focus on needlestick injury prevention, expansion of point-of-care testing applications.

Global Safety Lancet Market Segmentation

1) By Product Type: Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet 2) By Application: Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing 3) By End-User: Hospitals And Clinics, Diagnostic Centers And Pathology Laboratories, Home Diagnostics, Other End-Users Subsegments: 1) By Push Button Safety Lancet: Manual Push Button Safety Lancets, Automatic Push Button Safety Lancets, Adjustable Depth Push Button Safety Lancets 2) By Pressure Activated Safety Lancet: Single-Use Pressure Activated Lancets, Multi-Use Pressure Activated Lancets, Adjustable Pressure Activated Lancets 3) By Side Button Safety Lancet: Standard Side Button Safety Lancets, Ergonomic Side Button Safety Lancets, Adjustable Depth Side Button Safety Lancets

What Is The Driver Of The Safety Lancet Market?

The rising prevalence of diabetes is expected to propel the growth of the safety lancet market going forward. Diabetes is a chronic medical condition that occurs when the body cannot properly regulate blood sugar (glucose) levels. The prevalence of diabetes is rising due to increasing sedentary lifestyles, which lead to higher rates of obesity and insulin resistance in the population. Safety lancets are used in diabetes management to safely and conveniently obtain blood samples for glucose testing, minimizing the risk of infection and needle-stick injuries. For instance, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based charitable organization, around 4.4 million people in the UK are affected by diabetes, with type 1 diabetes accounting for about 8% of cases and type 2 diabetes comprising nearly 90%. Therefore, the rising prevalence of diabetes is driving the growth of the safety lancet industry.

Key Players In The Global Safety Lancet Market

Major companies operating in the safety lancet market are McKesson Corporation, Cardinal Health Inc., F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medline Industries Inc., Becton Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Nipro Corporation, Sarstedt AG & Co. KG., Greiner Bio-One International GmbH, Ypsomed Holding AG, Improve Medical Technology Co. Ltd, Omron Healthcare Inc., Owen Mumford Ltd., Arkray Inc., AgaMatrix Inc., Narang Medical Limited., DarioHealth Corp, HTL-STREFA S.A., Ribbel International Limited, Simple Diagnostics Inc., Sara Healthcare Private Limited, Smiths Medical, Sterimed Group

Global Safety Lancet Market Trends and Insights

Major companies operating in the safety lancet market are developing innovative devices, such as heel lancets, to enhance safety and accuracy in heel puncture procedures for infants, offering sterile, single-use lancets that reduce infection risk. Heel lancets are small, pointed devices used to prick the heel for blood sample collection, commonly utilized in newborn screening and diabetes monitoring. For instance, in October 2023, Owen Mumford, a UK-based medical solutions company, launched Unistik Heelstik neonatal and pediatric capillary blood sampling devices, which feature advanced safety mechanisms to ensure precise punctures while minimizing discomfort for infants and reducing the risk of needlestick injuries for healthcare professionals.

What Are Latest Mergers And Acquisitions In The Safety Lancet Market?

In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical devices company, acquired the pen needle and blood glucose monitoring (BGM) business from Ypsomed Holding AG. With this acquisition, MTD aims to expand its diabetes care portfolio, strengthen its position in the global insulin delivery and monitoring market, and integrate Ypsomed’s established product lines to offer comprehensive solutions for diabetes management. Ypsomed Holding AG is a Switzerland-based manufacturer of medical devices and diabetes care products that provides safety lancets.

Regional Outlook

North America was the largest region in the safety lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Safety Lancet Market?

The safety lancet market consists of sales of needle-free safety lancets, and specialized infant and pediatric safety lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.